| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $79.2M | -8.1% |
| R&D Expense | $163.5M | -0.6% |
| SG&A Expense | $52.9M | +16.3% |
| Operating Income | -$137.2M | -10.8% |
| Interest Expense | $5.1M | — |
| Pre-tax Income | -$131.0M | -7.2% |
| Income Tax | $2.8M | +751.5% |
| Net Income | -$133.8M | -9.9% |
| EPS (Basic) | -$6.38 |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $85.4M | +94.1% |
| Accounts Receivable | $8.6M | -57.6% |
| Current Assets | $422.8M | +35.6% |
| Total Assets | $462.3M | +23.1% |
| Current Liabilities | $62.8M | +110.5% |
| Total Liabilities | $245.5M | +354.1% |
| Stockholders' Equity | $216.7M | -32.6% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$103.2M | -21.7% |
| Capital Expenditures | $9.1M | +326.3% |
| Investing Cash Flow | -$53.6M | -197.6% |
| Financing Cash Flow | $198.1M | +889.0% |
| Free Cash Flow | -$112.2M | -29.1% |
| -8.0% |
| EPS (Diluted) | -$6.38 | -8.0% |